Patent foramen ovale: anatomy, outcomes, and closure

PA Calvert, BS Rana, AC Kydd… - Nature Reviews Cardiology, 2011 - nature.com
Patent foramen ovale (PFO) is a normal fetal communication between the right and left atria
that persists after birth. PFO is a common finding that occurs in 20–34% of the population …

Patent foramen ovale closure for secondary stroke prevention

M Alkhouli, H Sievert, DR Holmes - European heart journal, 2019 - academic.oup.com
Transcatheter closure of patent foramen ovale (PFO) in patients with cryptogenic stroke is
gaining momentum after the recent publication of four randomized clinical trials suggesting …

Patent foramen ovale

S Homma, SR Messé, T Rundek, YP Sun… - Nature reviews Disease …, 2016 - nature.com
Patent foramen ovale (PFO) is the most common congenital heart abnormality of fetal origin
and is present in approximately∼ 25% of the worldwide adult population. PFO is the …

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis

AR Khan, AA Bin Abdulhak, MA Sheikh, S Khan… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: This study sought to perform a meta-analysis of randomized controlled trials
comparing device closure with medical therapy in the prevention of recurrent neurological …

Patent foramen ovale: a comprehensive review

MK Teshome, K Najib, CC Nwagbara… - Current problems in …, 2020 - Elsevier
Foramen ovale is an embryonic defect in the interatrial septum which allows passage of
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …

Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices

TLP Slottow, DH Steinberg, R Waksman - Circulation, 2007 - Am Heart Assoc
Patent foramen ovales (PFOs) are common congenital cardiac defects that are more
prevalent among patients experiencing cryptogenic stroke than among those with strokes of …

[HTML][HTML] Patent foramen ovale closure in 2019

JP Giblett, O Abdul-Samad, LM Shapiro… - Interventional …, 2019 - ncbi.nlm.nih.gov
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of
the adult population. For most people it is a benign finding; however, in some the PFO can …

Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke

L Søndergaard, SE Kasner, JF Rhodes… - … England Journal of …, 2017 - Mass Medical Soc
Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …

[HTML][HTML] Patent foramen ovale closure: state of the art

JP Giblett, LK Williams, S Kyranis… - Interventional …, 2020 - ncbi.nlm.nih.gov
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of
the adult population. For most people, it is a benign finding; however, in some people, the …

Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale

R Gevorgyan Fleming, P Kumar, B West… - Catheterization and …, 2020 - Wiley Online Library
Objectives To compare residual shunt rate and complications associated with six different
devices used for PFO closure. Background Transcutaneous PFO closure is an effective …